Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - OTHER FINANCING ACTIVITIES
Other Financing Activities KALV - KalVista Pharmaceuticals, Inc.
53.8 M
LAST VALUE
483.18%
2 YEAR CAGR
194.68%
5 YEAR CAGR
24.50%
10 YEAR CAGR